TransMedics to Present at the Canaccord Genuity 44th Annual Growth Conference

Rhea-AI Summary

TransMedics Group (Nasdaq: TMDX), a medical technology company revolutionizing organ transplant therapy, has announced its participation in the Canaccord Genuity 44th Annual Growth Conference. The event will take place at the InterContinental Boston Hotel on Tuesday, August 13, 2024.

Key details of the presentation:

• Date: Tuesday, August 13, 2024
• Time: 9:30 a.m. Eastern Standard Time
• Location: InterContinental Boston Hotel

Investors and interested parties can access a live and archived webcast of the fireside chat through the 'Investors' section of the TransMedics website at https://investors.transmedics.com/.

News Market Reaction – TMDX

-0.41%

-0.41% Session move

In the trading session that priced this news, TMDX declined 0.41%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ANDOVER, Mass., July 29, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will present at the upcoming Canaccord Genuity 44^th Annual Growth Conference at the InterContinental Boston Hotel. Management is scheduled to present on Tuesday, August 13, 2024, at 9:30 a.m. Eastern Standard Time.

Event: Canaccord Genuity 44^th Annual Growth Conference 
Date: Tuesday, August 13, 2024 
Time: 9:30 a.m. ET 

A live and archived webcast of the fireside chat will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/. 

About TransMedics Group, Inc. 
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact: 
Brian Johnston 
631-807-1986 
Investors@transmedics.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-present-at-the-canaccord-genuity-44th-annual-growth-conference-302208688.html

SOURCE TransMedics Group, Inc.

FAQ

When is TransMedics (TMDX) presenting at the Canaccord Genuity Growth Conference?

TransMedics (TMDX) is scheduled to present at the Canaccord Genuity 44th Annual Growth Conference on Tuesday, August 13, 2024, at 9:30 a.m. Eastern Standard Time.

Where can I watch the TransMedics (TMDX) presentation at the Canaccord Genuity conference?

A live and archived webcast of TransMedics' (TMDX) presentation will be available on the 'Investors' section of the TransMedics website at https://investors.transmedics.com/.

What is the focus of TransMedics (TMDX) as a medical technology company?

TransMedics (TMDX) is a medical technology company that focuses on transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure.

Where is the Canaccord Genuity 44th Annual Growth Conference being held?

The Canaccord Genuity 44th Annual Growth Conference is being held at the InterContinental Boston Hotel.